Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
Abstract Introduction Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society. The objective of this study was to understand different perspectives on the challenges associated with the clin...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-12-01
|
Series: | Ophthalmology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40123-024-01061-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841544920940150784 |
---|---|
author | Anat Loewenstein Michelle Sylvanowicz Winfried M. Amoaku Tariq Aslam Chui Ming Gemmy Cheung Bora Eldem Robert P. Finger Richard P. Gale Laurent Kodjikian Adrian Koh Jean-François Korobelnik Xiaofeng Lin Paul Mitchell Moira Murphy Mali Okada Ian Pearce Francisco J. Rodriguez Jude Stern S. James Talks David T. Wong Tien Yin Wong Focke Ziemssen Jane Barratt |
author_facet | Anat Loewenstein Michelle Sylvanowicz Winfried M. Amoaku Tariq Aslam Chui Ming Gemmy Cheung Bora Eldem Robert P. Finger Richard P. Gale Laurent Kodjikian Adrian Koh Jean-François Korobelnik Xiaofeng Lin Paul Mitchell Moira Murphy Mali Okada Ian Pearce Francisco J. Rodriguez Jude Stern S. James Talks David T. Wong Tien Yin Wong Focke Ziemssen Jane Barratt |
author_sort | Anat Loewenstein |
collection | DOAJ |
description | Abstract Introduction Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society. The objective of this study was to understand different perspectives on the challenges associated with the clinical management of neovascular age-related macular degeneration, which could elucidate measures to comprehensively improve clinical care and outcomes. Methods A survey was carried out of patients with neovascular age-related macular degeneration, their providers, and clinic staff in 77 clinics across 24 countries on six continents, from a diverse range of healthcare systems, settings, and reimbursement models. Surveys comprised a series of single/multiple-response questions completed anonymously. Data gathered included patient personal characteristics, appointment attendance challenges, treatment experiences, and opportunities to improve support. Provider and clinic staff surveys asked similar questions about their perspectives; clinic characteristics were also captured. Results There were 6425 responses; 4558 patients with neovascular age-related macular degeneration, 659 providers, and 1208 clinic staff. Challenges identified included concern about patient burden to family/friends, high frequency of treatment, difficulties in traveling to appointments, long waiting times, and insufficient comprehension of neovascular age-related macular degeneration. Participants identified logistical (improved financial assistance with treatment and out-of-pocket costs, and appointment reminders), operational (addressing clinic set up to reduce waiting times and improving the amount of time providers spend with patients), and educational (improving quality and provision of patient information and expectation-setting) opportunities to improve care. Conclusions The wealth of data generated by this global survey highlights the breadth of challenges associated with clinical management of patients with neovascular age-related macular degeneration. Addressing the opportunities raised could improve patient adherence to treatment and potentially outcomes, reduce appointment burden, and increase clinic capacity. |
format | Article |
id | doaj-art-21c6b95a1b7944e986dd7a4a1f8ebcf6 |
institution | Kabale University |
issn | 2193-8245 2193-6528 |
language | English |
publishDate | 2024-12-01 |
publisher | Adis, Springer Healthcare |
record_format | Article |
series | Ophthalmology and Therapy |
spelling | doaj-art-21c6b95a1b7944e986dd7a4a1f8ebcf62025-01-12T12:10:45ZengAdis, Springer HealthcareOphthalmology and Therapy2193-82452193-65282024-12-0114121122810.1007/s40123-024-01061-3Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular DegenerationAnat Loewenstein0Michelle Sylvanowicz1Winfried M. Amoaku2Tariq Aslam3Chui Ming Gemmy Cheung4Bora Eldem5Robert P. Finger6Richard P. Gale7Laurent Kodjikian8Adrian Koh9Jean-François Korobelnik10Xiaofeng Lin11Paul Mitchell12Moira Murphy13Mali Okada14Ian Pearce15Francisco J. Rodriguez16Jude Stern17S. James Talks18David T. Wong19Tien Yin Wong20Focke Ziemssen21Jane Barratt22Department of Ophthalmology, Tel Aviv Medical Center, Faculty of Medicine, Tel Aviv UniversityBayer Consumer Care AGUniversity of Nottingham and Queen’s Medical CentreManchester Royal Eye Hospital, NHS Central Manchester University Hospitals and University of ManchesterDuke-NUS Medical School, National University of SingaporeDepartment of Ophthalmology, Hacettepe UniversityDepartment of Ophthalmology, University Medical Centre Mannheim, University of HeidelbergYork and Scarborough Teaching Hospital NHS Foundation TrustCroix-Rousse University Hospital, University of LyonEye and Retina Surgeons, Camden Medical CentreService d’Ophtalmologie, CHU BordeauxZhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen UniversityUniversity of Sydney (Westmead Institute for Medical Research)Exploristics LtdRoyal Victorian Eye and Ear HospitalRoyal Liverpool University HospitalFundación Oftalmologia Nacional, Escuela de Medicina y Ciencias de la Salud, Universidad del RosarioThe International Agency for the Prevention of BlindnessThe Newcastle Upon Tyne Hospitals NHS FoundationDepartment of Ophthalmology and Vision Sciences, University of Toronto, Unity Health Toronto, St. Michael’s HospitalSingapore Eye Research Institute (SERI)Department of Ophthalmology, University Hospital LeipzigInternational Federation on AgeingAbstract Introduction Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society. The objective of this study was to understand different perspectives on the challenges associated with the clinical management of neovascular age-related macular degeneration, which could elucidate measures to comprehensively improve clinical care and outcomes. Methods A survey was carried out of patients with neovascular age-related macular degeneration, their providers, and clinic staff in 77 clinics across 24 countries on six continents, from a diverse range of healthcare systems, settings, and reimbursement models. Surveys comprised a series of single/multiple-response questions completed anonymously. Data gathered included patient personal characteristics, appointment attendance challenges, treatment experiences, and opportunities to improve support. Provider and clinic staff surveys asked similar questions about their perspectives; clinic characteristics were also captured. Results There were 6425 responses; 4558 patients with neovascular age-related macular degeneration, 659 providers, and 1208 clinic staff. Challenges identified included concern about patient burden to family/friends, high frequency of treatment, difficulties in traveling to appointments, long waiting times, and insufficient comprehension of neovascular age-related macular degeneration. Participants identified logistical (improved financial assistance with treatment and out-of-pocket costs, and appointment reminders), operational (addressing clinic set up to reduce waiting times and improving the amount of time providers spend with patients), and educational (improving quality and provision of patient information and expectation-setting) opportunities to improve care. Conclusions The wealth of data generated by this global survey highlights the breadth of challenges associated with clinical management of patients with neovascular age-related macular degeneration. Addressing the opportunities raised could improve patient adherence to treatment and potentially outcomes, reduce appointment burden, and increase clinic capacity.https://doi.org/10.1007/s40123-024-01061-3nAMDNeovascular age-related macular degenerationPatient experience |
spellingShingle | Anat Loewenstein Michelle Sylvanowicz Winfried M. Amoaku Tariq Aslam Chui Ming Gemmy Cheung Bora Eldem Robert P. Finger Richard P. Gale Laurent Kodjikian Adrian Koh Jean-François Korobelnik Xiaofeng Lin Paul Mitchell Moira Murphy Mali Okada Ian Pearce Francisco J. Rodriguez Jude Stern S. James Talks David T. Wong Tien Yin Wong Focke Ziemssen Jane Barratt Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration Ophthalmology and Therapy nAMD Neovascular age-related macular degeneration Patient experience |
title | Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration |
title_full | Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration |
title_fullStr | Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration |
title_full_unstemmed | Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration |
title_short | Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration |
title_sort | global insights from patients providers and staff on challenges and solutions in managing neovascular age related macular degeneration |
topic | nAMD Neovascular age-related macular degeneration Patient experience |
url | https://doi.org/10.1007/s40123-024-01061-3 |
work_keys_str_mv | AT anatloewenstein globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT michellesylvanowicz globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT winfriedmamoaku globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT tariqaslam globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT chuiminggemmycheung globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT boraeldem globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT robertpfinger globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT richardpgale globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT laurentkodjikian globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT adriankoh globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT jeanfrancoiskorobelnik globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT xiaofenglin globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT paulmitchell globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT moiramurphy globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT maliokada globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT ianpearce globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT franciscojrodriguez globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT judestern globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT sjamestalks globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT davidtwong globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT tienyinwong globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT fockeziemssen globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration AT janebarratt globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration |